Shanghai Extends Pilot Scheme for Importing Biomedical R&D and Testing Supplies to October 2028

Deep News10-22

Multiple government departments in Shanghai have announced an extension of the validity period for a pilot program governing the import of items used in biomedical research and testing.

The notice was issued jointly by the Shanghai Municipal Commission of Commerce, the Shanghai Customs of the People's Republic of China, the Shanghai Medical Products Administration, the Shanghai Municipal Bureau of Ecology and Environment, the Shanghai Municipal Commission of Agriculture and Rural Affairs, and the Shanghai Municipal Commission of Science and Technology.

The notice was addressed to commerce authorities, market supervision bureaus, ecology and environment bureaus, agriculture and rural affairs commissions, and science and technology management departments across all districts of Shanghai, as well as to customs offices under Shanghai Customs and the Administration Committee of the Lin-gang Special Area.

According to the announcement, an evaluation concluded that the Shanghai Pilot Scheme for the Import of Items Used in Biomedical Research and Development and Testing (Shanghai Commerce Regulation [2024] No. 12) needs to continue being implemented.

The scheme's validity period has therefore been extended through October 31, 2028.

The notice was dated October 15, 2026, and the information was released by the Shanghai Municipal People's Government.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment